Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy

AIM: To probe into the related influencing factors of serum lipoprotein associated phospholipase A2(Lp-PLA2)level in patients with diabetic retinopathy. <p>METHODS: Totally 174 cases of patients with type 2 diabetes mellitus and who treated in Department of Endocrinology from September 2015 to...

Full description

Bibliographic Details
Main Authors: Zhao-Hui Hui, Yong-Ding Zhang, Qing-Xia Zhang, Yan Sun, Qiong-Mei Shi, Fang Ma
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2018-12-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2018/12/201812021.pdf
id doaj-61f0ba8fd26a4b9bba25e92ca82a911e
record_format Article
spelling doaj-61f0ba8fd26a4b9bba25e92ca82a911e2020-11-25T00:46:31ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232018-12-0118122213221610.3980/j.issn.1672-5123.2018.12.21Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathyZhao-Hui Hui0Yong-Ding Zhang1Qing-Xia Zhang2Yan Sun3Qiong-Mei Shi4Fang Ma5Clinical Laboratory Center, Community Health Management Center, Xili People's Hospital of Nanshan District, Shenzhen 518055, Guangdong Province, ChinaClinical Laboratory, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518055, Guangdong Province, ChinaClinical Laboratory, Sixth People's Hospital of Shenzhen, Shenzhen 518055, Guangdong Province, ChinaClinical Laboratory Center, Community Health Management Center, Xili People's Hospital of Nanshan District, Shenzhen 518055, Guangdong Province, ChinaClinical Laboratory Center, Community Health Management Center, Xili People's Hospital of Nanshan District, Shenzhen 518055, Guangdong Province, ChinaClinical Laboratory Center, Community Health Management Center, Xili People's Hospital of Nanshan District, Shenzhen 518055, Guangdong Province, ChinaAIM: To probe into the related influencing factors of serum lipoprotein associated phospholipase A2(Lp-PLA2)level in patients with diabetic retinopathy. <p>METHODS: Totally 174 cases of patients with type 2 diabetes mellitus and who treated in Department of Endocrinology from September 2015 to September 2017 were selected as the research objects, and were divided into the non-diabetic retinopathy group(NDR), non-proliferative diabetic retinopathy group(NPDR)and proliferative diabetic retinopathy group(PDR)according to the results of fundus examination. Then, the age, sex, body mass index(BMI), blood pressure, blood glucose, blood lipids, vascular endothelial growth factor(VEGF), C-reactive protein(CRP), and Lp-PLA2 levels and other clinical data of three groups of patients were collected and compared. <p>RESULTS: There was significant differences in the duration of diabetes, fasting blood glucose(FBP), 2h postprandial blood glucose(2hBP), HbA1c, triacylglycerol(TG), total cholesterol(TC), high density lipoprotein cholesterol(HDL-C), low density lipoprotein cholesterol(LDL-C), VEGF, CRP, Lp-PLA2 between the three groups of patients(<i>P</i><0.05). There was no significant difference in serum TG, TC, HDL-C and CRP levels between NPDR group and NDR group(<i>P</i>>0.05). While there was significant difference in biochemical indexes of patients between PDR group and NDR group(<i>P</i><0.05). The VEGF, CRP and Lp-PLA2 in the PDR group were significantly higher than those in the NPDR group, and the difference was statistically significant(<i>P</i><0.05). Pearson correlation analysis found that the serum Lp-PLA2 was positively correlated with age, course of disease, 2hBG, TG, VEGF and CRP(<i>P</i><0.05). Multiple linear regression analysis showed that serum Lp-PLA2 was positively correlated with the course of diabetes mellitus and serum level of VEGF(<i>P</i><0.05). <p>CONCLUSION: The level of serum Lp-PLA2 in patients with diabetic retinopathy are significantly increased, which the level is positively correlated with the duration of diabetes and serum VEGF level, thus it can be used as diagnostic index for diabetic retinopathy.http://ies.ijo.cn/cn_publish/2018/12/201812021.pdfdiabetic retinopathyserum lipoprotein-associated phospholipase A2blood lipidblood glucosevascular endothelial growth factor
collection DOAJ
language English
format Article
sources DOAJ
author Zhao-Hui Hui
Yong-Ding Zhang
Qing-Xia Zhang
Yan Sun
Qiong-Mei Shi
Fang Ma
spellingShingle Zhao-Hui Hui
Yong-Ding Zhang
Qing-Xia Zhang
Yan Sun
Qiong-Mei Shi
Fang Ma
Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
Guoji Yanke Zazhi
diabetic retinopathy
serum lipoprotein-associated phospholipase A2
blood lipid
blood glucose
vascular endothelial growth factor
author_facet Zhao-Hui Hui
Yong-Ding Zhang
Qing-Xia Zhang
Yan Sun
Qiong-Mei Shi
Fang Ma
author_sort Zhao-Hui Hui
title Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
title_short Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
title_full Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
title_fullStr Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
title_full_unstemmed Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
title_sort influencing factors of serum lp-pla2 level in patients with diabetic retinopathy
publisher Press of International Journal of Ophthalmology (IJO PRESS)
series Guoji Yanke Zazhi
issn 1672-5123
1672-5123
publishDate 2018-12-01
description AIM: To probe into the related influencing factors of serum lipoprotein associated phospholipase A2(Lp-PLA2)level in patients with diabetic retinopathy. <p>METHODS: Totally 174 cases of patients with type 2 diabetes mellitus and who treated in Department of Endocrinology from September 2015 to September 2017 were selected as the research objects, and were divided into the non-diabetic retinopathy group(NDR), non-proliferative diabetic retinopathy group(NPDR)and proliferative diabetic retinopathy group(PDR)according to the results of fundus examination. Then, the age, sex, body mass index(BMI), blood pressure, blood glucose, blood lipids, vascular endothelial growth factor(VEGF), C-reactive protein(CRP), and Lp-PLA2 levels and other clinical data of three groups of patients were collected and compared. <p>RESULTS: There was significant differences in the duration of diabetes, fasting blood glucose(FBP), 2h postprandial blood glucose(2hBP), HbA1c, triacylglycerol(TG), total cholesterol(TC), high density lipoprotein cholesterol(HDL-C), low density lipoprotein cholesterol(LDL-C), VEGF, CRP, Lp-PLA2 between the three groups of patients(<i>P</i><0.05). There was no significant difference in serum TG, TC, HDL-C and CRP levels between NPDR group and NDR group(<i>P</i>>0.05). While there was significant difference in biochemical indexes of patients between PDR group and NDR group(<i>P</i><0.05). The VEGF, CRP and Lp-PLA2 in the PDR group were significantly higher than those in the NPDR group, and the difference was statistically significant(<i>P</i><0.05). Pearson correlation analysis found that the serum Lp-PLA2 was positively correlated with age, course of disease, 2hBG, TG, VEGF and CRP(<i>P</i><0.05). Multiple linear regression analysis showed that serum Lp-PLA2 was positively correlated with the course of diabetes mellitus and serum level of VEGF(<i>P</i><0.05). <p>CONCLUSION: The level of serum Lp-PLA2 in patients with diabetic retinopathy are significantly increased, which the level is positively correlated with the duration of diabetes and serum VEGF level, thus it can be used as diagnostic index for diabetic retinopathy.
topic diabetic retinopathy
serum lipoprotein-associated phospholipase A2
blood lipid
blood glucose
vascular endothelial growth factor
url http://ies.ijo.cn/cn_publish/2018/12/201812021.pdf
work_keys_str_mv AT zhaohuihui influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
AT yongdingzhang influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
AT qingxiazhang influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
AT yansun influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
AT qiongmeishi influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
AT fangma influencingfactorsofserumlppla2levelinpatientswithdiabeticretinopathy
_version_ 1725264894952996864